Nano Parthenolide Improves Intestinal Barrier Function of Sepsis by Inhibiting Apoptosis and ROS via 5-HTR2A

References

• Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the global burden of disease study. Lancet. 2020;395(10219):200–211. doi:10.1016/S0140-6736(19)32989-7
   PubMed Web of Science ®Google Scholar
• Rajaee A, Barnett R, Cheadle WG. Pathogen- and danger-associated molecular patterns and the cytokine response in sepsis. Surg Infect. 2018;19(2):107–116. doi:10.1089/sur.2017.264
   PubMed Web of Science ®Google Scholar
• Wang C, Li Q, Ren J. Microbiota-immune interaction in the pathogenesis of gut-derived infection. Front Immunol. 2019;10:1873. doi:10.3389/fimmu.2019.01873
   PubMed Web of Science ®Google Scholar
• Peng Z, Niu Z, Zhang R, et al. Antimicrobial step-down therapy versus conventional antimicrobial therapy in the treatment of patients with sepsis. Dis Markers. 2022;2022:3117805. doi:10.1155/2022/3117805.eCollection2022
   PubMedGoogle Scholar
• Dong Y, Qian X, Li J. Sesquiterpene lactones and cancer: new insight into antitumor and anti-inflammatory effects of parthenolide-derived dimethylaminomicheliolide and micheliolide. Comput Math Methods Med. 2022;2022:3744837. doi:10.1155/2022/3744837
   PubMed Web of Science ®Google Scholar
• Wang D, Wang H, Fu S, et al. Parthenolide ameliorates concanavalin A-induced acute hepatitis in mice and modulates the macrophages to an anti-inflammatory state. Int Immunopharmacol. 2016;38:132–138. doi:10.1016/j.intimp.2016.05.024
   PubMed Web of Science ®Google Scholar
• Zhang Y, Miao L, Peng Q, et al. Parthenolide modulates cerebral ischemia-induced microglial polarization and alleviates neuroinflammatory injury via the RhoA/ROCK pathway. Phytomedicine. 2022;105:154373. doi:10.1016/j.phymed.2022.154373
   PubMed Web of Science ®Google Scholar
• CuiZ-Y, Wang G, Zhang J, et al. Parthenolide, bioactive compound of Chrysanthemum parthenium L., ameliorates fibrogenesis and inflammation in hepatic fibrosis via regulating the crosstalk of TLR4 and STAT3 signaling pathway. Phytother Res. 2021;35(10):5680–5693. doi:10.1002/ptr.7214
   PubMed Web of Science ®Google Scholar
• Dong L, Qiao H, Zhang X, et al. Parthenolide is neuroprotective in rat experimental stroke model: downregulating NF-κB, phospho-p38MAPK, and caspase-1 and ameliorating BBB permeability. Mediators Inflamm. 2013;2013:370804. doi:10.1155/2013/370804
   PubMed Web of Science ®Google Scholar
• Sheehan M, Wong HR, Hake PW, Zingarelli B. Parthenolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis. Crit Care Med. 2003;31(9):2263–2270. doi:10.1097/01.CCM.0000085186.14867.F7
   PubMed Web of Science ®Google Scholar
• Kim SL, Liu YC, Seo SY, et al. Parthenolide induces apoptosis in colitis-associated colon cancer, inhibiting NF-κB signaling. Oncol Lett. 2015;9(5):2135–2142. doi:10.3892/ol.2015.3017
   PubMed Web of Science ®Google Scholar
• Sun R, Dai J, Ling M, et al. Delivery of triptolide: a combination of traditional Chinese medicine and nanomedicine. J Nanobiotechnology. 2022;20(1):194. doi:10.1186/s12951-022-01389-7
   PubMed Web of Science ®Google Scholar
• Zewail M, Gaafar E, Ali MM, Abbas H. Lipidic cubic-phase leflunomide nanoparticles (cubosomes) as a potential tool for breast cancer management. Drug Deliv. 2022;29(1):1663–1674. doi:10.1080/10717544.2022.2079770
   PubMed Web of Science ®Google Scholar
• Xi J, Fang JH, Xiong XM, et al. Acid water-ground nano-realgar is superior to crude realgar in promoting apoptosis of MCF-7 breast cancer cells. Curr Med Sci. 2022;42(4):720–732. doi:10.1007/s11596-022-2605-5
   PubMed Web of Science ®Google Scholar
• Wang C, Li F, Zhang T, Yu M, Sun Y. Recent advances in anti-multidrug resistance for nano-drug delivery system. Drug Deliv. 2022;29(1):1684–1697. doi:10.1080/10717544.2022.2079771
   PubMed Web of Science ®Google Scholar
• Salatin S, Yari Khosroushahi A. Overviews on the cellular uptake mechanism of polysaccharide colloidal nanoparticles. J Cell Mol Med. 2017;21(9):1668–1686. doi:10.1111/jcmm.13110
   PubMed Web of Science ®Google Scholar
• Sadegha S, Varshochian R, Dadras P, et al. Mesoporous silica coated SPIONs containing curcumin and silymarin intended for breast cancer therapy. Daru. 2022;30(2):331–341. doi:10.1007/s40199-022-00453-9
   PubMed Web of Science ®Google Scholar
• She H, Hu Y, Zhou Y, et al. Protective effects of dexmedetomidine on sepsis-induced vascular leakage by alleviating ferroptosis via regulating metabolic reprogramming. J Inflamm Res. 2021;14:6765–6782. doi:10.2147/JIR.S340420
   PubMed Web of Science ®Google Scholar
• Zhu HJ, Wang JS, Markowitz JS, Donovan JL, Gibson BB, DeVane CL. Risperidone and paliperidone inhibit p-glycoprotein activity in vitro. Neuropsychopharmacology. 2007;32(4):757–764. doi:10.1038/sj.npp.1301181
   PubMed Web of Science ®Google Scholar
• Zheng D, Zhou H, Wang H, et al. Mesenchymal stem cell-derived microvesicles improve intestinal barrier function by restoring mitochondrial dynamic balance in sepsis rats. Stem Cell Res Ther. 2021;12(1):299. doi:10.1186/s13287-021-02363-0
   PubMed Web of Science ®Google Scholar
• Greco E, Lupia E, Bosco O, Vizio B, Montrucchio G. Platelets and multi-organ failure in sepsis. Int J Mol Sci. 2017;18(10):2200. doi:10.3390/ijms18102200
   PubMed Web of Science ®Google Scholar
• Fay KT, Ford ML, Coopersmith CM. The intestinal microenvironment in sepsis. Biochim Biophys Acta Mol Basis Dis. 2017;1863(10 Pt B):2574–2583. doi:10.1016/j.bbadis.2017.03.005
   PubMed Web of Science ®Google Scholar
• Huang M, Cai S, Su J. The pathogenesis of sepsis and potential therapeutic targets. Int J Mol Sci. 2019;20(21):5376. doi:10.3390/ijms20215376
   PubMed Web of Science ®Google Scholar
• Li H, Xie J, Guo X, et al. Bifidobacterium spp. and their metabolite lactate protect against acute pancreatitis via inhibition of pancreatic and systemic inflammatory responses. Gut Microbes. 2022;14(1):2127456. doi:10.1080/19490976.2022.2127456
   PubMed Web of Science ®Google Scholar
• Cigarran Guldris S, González Parra E, Cases Amenós A. Gut microbiota in chronic kidney disease. Microbiota intestinal en la enfermedad renal crónica. Nefrologia. 2017;37(1):9–19. doi:10.1016/j.nefro.2016.05.008
   PubMedGoogle Scholar
• Xu S, Li L, Wu J, et al. Melatonin attenuates sepsis-induced small-intestine injury by upregulating SIRT3-mediated oxidative-stress inhibition, mitochondrial protection, and autophagy induction. Front Immunol. 2021;12:625627. doi:10.3389/fimmu.2021.625627
   PubMed Web of Science ®Google Scholar
• Tsai TY, Chan P, Gong CL, et al. Parthenolide-induced cytotoxicity in H9c2 cardiomyoblasts involves oxidative stress. Acta Cardiol Sin. 2015;31(1):33–41. doi:10.6515/acs20140422b
   PubMed Web of Science ®Google Scholar
• Malekzadeh M, Kia SJ, Mashaei L, Moosavi MS. Oral nano-curcumin on gingival inflammation in patients with gingivitis and mild periodontitis. Clin Exp Dent Res. 2021;7(1):78–84. doi:10.1002/cre2.330
   PubMed Web of Science ®Google Scholar
• de Oliveira Carvalho H, Gonçalves D, Picanço K, et al. Actions of Cannabis sativa L. fixed oil and nano-emulsion on venom-induced inflammation of Bothrops moojeni snake in rats. Inflammopharmacology. 2021;29(1):123–135. doi:10.1007/s10787-020-00754-y
   PubMed Web of Science ®Google Scholar
• Al-Hazmi NE, Naguib DM. Nano-peroxidase a promising anti-inflammatory and antibacterial agent against bacteria and inflammation related to colorectal cancer. J Gastrointest Cancer. 2022;53(2):415–419. doi:10.1007/s12029-021-00626-w
   PubMed Web of Science ®Google Scholar
• Ganugula R, Arora M, Jaisamut P, et al. Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic beta cells for effective management of type 1 diabetes mellitus. Br J Pharmacol. 2017;174(13):2074–2084. doi:10.1111/bph.13816
   PubMed Web of Science ®Google Scholar
• Botella P, Muniesa C, Vicente V, Cabrera-García A. Effect of drug precursor in cell uptake and cytotoxicity of redox-responsive camptothecin nanomedicines. Mater Sci Eng C Mater Biol Appl. 2016;58:692–699. doi:10.1016/j.msec.2015.09.012
   PubMed Web of Science ®Google Scholar
• Ren Y, Li Y, Lv J, et al. Parthenolide regulates oxidative stress-induced mitophagy and suppresses apoptosis through p53 signaling pathway in C2C12 myoblasts. Cell Biochem. 2019;120(9):15695–15708. doi:10.1002/jcb.28839
   PubMed Web of Science ®Google Scholar
• Li QS, Jia YJ. Ferroptosis: a critical player and potential therapeutic target in traumatic brain injury and spinal cord injury. Neural Regen Res. 2023;18(3):506–512. doi:10.4103/1673-5374.350187
   PubMed Web of Science ®Google Scholar
• Hu Q, Ren H, Li G, et al. STING-mediated intestinal barrier dysfunction contributes to lethal sepsis. EBioMedicine. 2019;41:497–508. doi:10.1016/j.ebiom.2019.02.055
   PubMed Web of Science ®Google Scholar
• Zou Z, Liu B, Zeng L, et al. Cx43 inhibition attenuates sepsis-induced intestinal injury via downregulating ROS transfer and the activation of the JNK1/Sirt1/FoxO3a signaling pathway. Mediators Inflamm. 2019;2019:7854389. doi:10.1155/2019/7854389
   PubMed Web of Science ®Google Scholar
• Zha L, Chen J, Sun S, et al. Soyasaponins can blunt inflammation by inhibiting the reactive oxygen species-mediated activation of PI3K/Akt/NF-kB pathway. PLoS One. 2014;9(9):e107655. doi:10.1371/journal.pone.0107655
   PubMed Web of Science ®Google Scholar
• Mohammadi A, Rashidi E, Amooeian VG. Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia. Psychiatry Res. 2018;265:25–38. doi:10.1016/j.psychres.2018.04.036
   PubMed Web of Science ®Google Scholar
• Borkowski LF, Smith CL, Keilholz AN, Nichols NL. Divergent receptor utilization is necessary for phrenic long-term facilitation over the course of motor neuron loss following CTB-SAP intrapleural injections. Neurophysiol. 2021;126(3):709–722. doi:10.1152/jn.00236.2021
   PubMedGoogle Scholar
• Zhao H, Chen S, Hu K, et al. 5-HTP decreases goat mammary epithelial cells apoptosis through MAPK/ERK/Bcl-3 pathway. Gene. 2021;769:145240. doi:10.1016/j.gene.2020.145240
   PubMed Web of Science ®Google Scholar
• Takeshima T, Komori M, Tanji Y, Ozeki A, Tatsuoka Y. Efficacy of lasmiditan across patient and migraine characteristics in Japanese patients with migraine: a secondary analysis of the MONONOFU trial. Adv Ther. 2022;39(11):5274–5288. doi:10.1007/s12325-022-02304-0
   PubMed Web of Science ®Google Scholar